The invention relates to heterocyclic compounds, compositions including the compounds and methods of using and methods of making thereof. The compounds (and compositions) are useful, inter alia, in modulating IL-12 production and processes mediated by IL-12.
The invention relates to heterocyclic compounds, compositions including the compounds and methods of using and methods of making thereof. The compounds (and compositions) are useful, inter alia, in modulating IL-12 production and processes mediated by IL-12.
Method for treating B cell regulated autoimmune disorders
申请人:Foley Kevin
公开号:US20070032493A1
公开(公告)日:2007-02-08
The invention relates to a method for treating B-cell regulated autoimmune disorders using compounds that modulate the activity of c-Rel.
PROCESS FOR PREPARING MESYLATE SALTS OF IL-12 INHIBITORY COMPOUNDS
申请人:Kostik Elena
公开号:US20090163708A1
公开(公告)日:2009-06-25
This invention relates to a method of preparing mesylate salts of compounds that inhibit IL-12, IL-23 and/or IL-27 production.
TOPICAL FORMULATIONS FOR THE TREATMENT OF PSORIASIS
申请人:Babu Suresh R.
公开号:US20110098267A1
公开(公告)日:2011-04-28
The invention relates to a topical composition and a method for treating psoriasis. The topical composition comprises one or more compound that inhibits the production of IL-12 and IL-23.